J Liver Cancer.  2025 Mar;25(1):7-8. 10.17998/jlc.2025.02.17.

Correspondence to editorial on “Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea”

• Han JW
• Kim BH

• KMID: 2567059
• DOI: http://doi.org/10.17998/jlc.2025.02.17

Reference

References

1. Hwang SY, Yang JD. Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea. J Liver Cancer. 2024; Dec. 5. doi: 10.17998/jlc.2024.12.04. [Epub ahead of print].

2. Han JW, Sohn W, Choi GH, Jang JW, Seo GH, Kim BH, et al. Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study. J Liver Cancer. 2024; 24:274–285.

3. Chon YE, Lee HA, Yoon JS, Park JY, Kim BH, Lee IJ, et al. Hepatocellular carcinoma in Korea between 2012 and 2014: an analysis of data from the Korean Nationwide Cancer Registry. J Liver Cancer. 2020; 20:135–147.

4. Kwon JW, Tchoe HJ, Lee J, Suh JK, Lee JH, Shin S. The impact of national surveillance for liver cancer: results from real-world setting in Korea. Gut Liver. 2020; 14:108–116.

5. Ciria R, Gomez-Luque I, Ocaña S, Cipriani F, Halls M, Briceño J, et al. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for hepatocellular carcinoma: updated results from the European Guidelines Meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017. Ann Surg Oncol. 2019; 26:252–263.

6. Pelizzaro F, Haxhi S, Penzo B, Vitale A, Giannini EG, Sansone V, et al. Transarterial chemoembolization for hepatocellular carcinoma in clinical practice: temporal trends and survival outcomes of an iterative treatment. Front Oncol. 2022; 12:822507.

7. Jeon D, Song GW, Lee HC, Shim JH. Treatment patterns for hepatocellular carcinoma in patients with Child-Pugh class B and their impact on survival: a Korean nationwide registry study. Liver Int. 2022; 42:2830–2842.